The Harbor Health editorial team includes physicians, pharmacists, and health writers dedicated to providing accurate, evidence-based information about weight management and GLP-1 medications.
Tirzepatide for Type 2 Diabetes and Weight Loss: Understanding the Dual Benefit
For the estimated 37 million Americans living with type 2 diabetes, the relationship between blood sugar management and weight loss has always been frustratingly circular: excess weight drives insulin resistance, insulin resistance makes weight loss harder, and many diabetes medications actually cause weight gain as a side effect.
Everything you need to know about GLP-1 receptor agonists — how they work, what to expect, and whether they might be right for your weight loss journey.
